Front Line Medical Technologies, a leader in innovative medical devices for emergency and trauma care, has announced the CE marking of its COBRA-OS® (Control of Bleeding, Resuscitation, Arterial Occlusion System). This groundbreaking device is the first 4 French aortic occlusion device to be approved under the new European Medical Device Regulations, providing EU medical providers with access to this life-saving technology. With FDA clearance and Health Canada approval already in place, the COBRA-OS® CE marking marks a significant expansion in Front Line Medical Technologies’ market reach and solidifies its position as a leading industry player.